MedTrace Logo

QT-Prolongation in Lung Transplantation

NCT02380365 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 720

Last updated 2015-03-05

No results posted yet for this study

Summary

Experimental intervention: electrocardiography. Control intervention: none

Duration of intervention per patient/subject:

5 min, observation 6 months

Key inclusion criteria:

* outpatients after lung transplantation (single, double or combined)
* outpatients on the wait list for lung transplantation

Key exclusion criteria:

• no informed consent

Conditions

  • Disorder Related to Lung Transplantation

Interventions

DEVICE

Electrocardiography

Duration of intervention per patient/subject: 5 min, observation 6 months

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Jens Gottlieb, MD · Hannover MS, Dpt Respiratory Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-04-30
Completion
2016-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380365 on ClinicalTrials.gov